Compare RZLT & HCAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RZLT | HCAC |
|---|---|---|
| Founded | 2010 | 2025 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 352.1M | 294.9M |
| IPO Year | 2011 | 2025 |
| Metric | RZLT | HCAC |
|---|---|---|
| Price | $4.00 | $10.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $10.40 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 41.9K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.47 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,517.77 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.07 | $9.92 |
| 52 Week High | $11.17 | $10.26 |
| Indicator | RZLT | HCAC |
|---|---|---|
| Relative Strength Index (RSI) | 46.33 | 81.85 |
| Support Level | $3.58 | $10.05 |
| Resistance Level | $4.22 | N/A |
| Average True Range (ATR) | 0.36 | 0.01 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 35.74 | 99.93 |
Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.
Hall Chadwick Acquisition Corp is a blank check company.